SLC5A2 and heart failure: Taken together, unremitting efforts to elucidate the molecular mechanism through which the administration of SGLT2 inhibitors alleviates heart failure, as well as clinical studies of these compounds for non-diabetic heart failure could shift their classification from merely anti-diabetic drugs to potent anti-heart failure drugs.